There
are mutations in the rapidly spreading types of the coronavirus, which help the
virus to some extent survive the immune response caused by the disease or
vaccine.

This
was revealed in a medical study conducted in the United States. 

coronavirus


Experts
from Germany and the Netherlands also worked on the Scrappers Research
Institute in the United States, which revealed important details about
mutations.

The
research examined how structural biology techniques were used to inactivate
virus-defying antibodies against the original and new types of the virus. The extent to which their actions affect species discovered in the UK, South
Africa, India, and Brazil.

Types
of Corona’s concern include Type B117 discovered in the UK, Type B1351
discovered in South Africa, Type P1 discovered in Brazil, and Type B1617
discovered in India.

These
types are considered more contagious than the original type of the virus that
spreads in Wuhan, and recent research reports have found that antibodies to
these types are less effective after being infected with the original virus or
after vaccination.

Because
it is thought that these new types can make people sick despite vaccinations in
some cases, experts have tried to figure out how these types can avoid an
immune response.

For
the study, experts focused on 417N, E484K, and N501Y of the three mutations in
the spike protein of the coronavirus.

Together
or separately, these mutations have been discovered in most new types of the corona,
all at the site of attachment to the virus’s receptor.

The
researchers examined the antibodies and found that most of these antibodies
significantly reduced the ability of the virus to bind and inactivate.

Using
structural imaging techniques, the researchers mapped out different parts of
the virus and examined how mutations affect the areas where antibodies bind and
inactivate the virus.

The
results suggest that antibodies are very effective against the original type of
the virus, but certain types can prevent it, so vaccines will need to be
updated gradually.

Similarly,
the study found that 3 mutations did not change the location of the receptor
binding.

The
results of the study were published in the medical journal Science.